Literature DB >> 22493750

Interactions between PPAR-α and inflammation-related cytokine genes on the development of Alzheimer's disease, observed by the Epistasis Project.

Reinhard Heun1, Heike Kölsch, Carla A Ibrahim-Verbaas, Onofre Combarros, Yurii S Aulchenko, Monique Breteler, Maaike Schuur, Cornelia M van Duijn, Naomi Hammond, Olivia Belbin, Mario Cortina-Borja, Gordon K Wilcock, Kristelle Brown, Rachel Barber, Patrick G Kehoe, Eliecer Coto, Victoria Alvarez, Michael G Lehmann, Panos Deloukas, Ignacio Mateo, Kevin Morgan, Donald R Warden, A David Smith, Donald J Lehmann.   

Abstract

OBJECTIVE: Neuroinflammation contributes to the pathogenesis of sporadic Alzheimer's disease (AD). Variations in genes relevant to inflammation may be candidate genes for AD risk. Whole-genome association studies have identified relevant new and known genes. Their combined effects do not explain 100% of the risk, genetic interactions may contribute. We investigated whether genes involved in inflammation, i.e. PPAR-α, interleukins (IL) IL- 1α, IL-1β, IL-6, and IL-10 may interact to increase AD risk.
METHODS: The Epistasis Project identifies interactions that affect the risk of AD. Genotyping of single nucleotide polymorphisms (SNPs) in PPARA, IL1A, IL1B, IL6 and IL10 was performed. Possible associations were analyzed by fitting logistic regression models with AD as outcome, controlling for centre, age, sex and presence of apolipoprotein ε4 allele (APOEε4). Adjusted synergy factors were derived from interaction terms (p<0.05 two-sided).
RESULTS: We observed four significant interactions between different SNPs in PPARA and in interleukins IL1A, IL1B, IL10 that may affect AD risk. There were no significant interactions between PPARA and IL6.
CONCLUSIONS: In addition to an association of the PPARA L162V polymorphism with the AD risk, we observed four significant interactions between SNPs in PPARA and SNPs in IL1A, IL1B and IL10 affecting AD risk. We prove that gene-gene interactions explain part of the heritability of AD and are to be considered when assessing the genetic risk. Necessary replications will require between 1450 and 2950 of both cases and controls, depending on the prevalence of the SNP, to have 80% power to detect the observed synergy factors.

Entities:  

Keywords:  AD; PPAR-alpha; epistasis; genetic interaction; genetics; inflammation; interleukin; sporadic; steroid receptors

Year:  2012        PMID: 22493750      PMCID: PMC3316448     

Source DB:  PubMed          Journal:  Int J Mol Epidemiol Genet        ISSN: 1948-1756


  34 in total

1.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.

Authors:  S S Mirra; A Heyman; D McKeel; S M Sumi; B J Crain; L M Brownlee; F S Vogel; J P Hughes; G van Belle; L Berg
Journal:  Neurology       Date:  1991-04       Impact factor: 9.910

2.  Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists.

Authors:  C K Combs; D E Johnson; J C Karlo; S B Cannady; G E Landreth
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

3.  Interaction of insulin and PPAR-α genes in Alzheimer's disease: the Epistasis Project.

Authors:  Heike Kölsch; Donald J Lehmann; Carla A Ibrahim-Verbaas; Onofre Combarros; Cornelia M van Duijn; Naomi Hammond; Olivia Belbin; Mario Cortina-Borja; Michael G Lehmann; Yurii S Aulchenko; Maaike Schuur; Monique Breteler; Gordon K Wilcock; Kristelle Brown; Patrick G Kehoe; Rachel Barber; Eliecer Coto; Victoria Alvarez; Panos Deloukas; Ignacio Mateo; Wolfgang Maier; Kevin Morgan; Donald R Warden; A David Smith; Reinhard Heun
Journal:  J Neural Transm (Vienna)       Date:  2011-11-08       Impact factor: 3.575

4.  Association between an interleukin-6 promoter and 3' flanking region haplotype and reduced Alzheimer's disease risk in a German population.

Authors:  M Bagli; A Papassotiropoulos; M Knapp; F Jessen; M Luise Rao; W Maier; R Heun
Journal:  Neurosci Lett       Date:  2000-04-07       Impact factor: 3.046

5.  Regulation of beta-amyloid stimulated proinflammatory responses by peroxisome proliferator-activated receptor alpha.

Authors:  C K Combs; P Bates; J C Karlo; G E Landreth
Journal:  Neurochem Int       Date:  2001 Nov-Dec       Impact factor: 3.921

6.  Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism.

Authors:  L M Grimaldi; V M Casadei; C Ferri; F Veglia; F Licastro; G Annoni; I Biunno; G De Bellis; S Sorbi; C Mariani; N Canal; W S Griffin; M Franceschi
Journal:  Ann Neurol       Date:  2000-03       Impact factor: 10.422

7.  Cytokine IL-1 beta but not IL-1 alpha promoter polymorphism is associated with Alzheimer disease in a population from the Canary Islands, Spain.

Authors:  M C Déniz-Naranjo; C Muñoz-Fernandez; M J Alemany-Rodríguez; M C Pérez-Vieitez; Y Aladro-Benito; J Irurita-Latasa; F Sánchez-García
Journal:  Eur J Neurol       Date:  2008-08-20       Impact factor: 6.089

8.  The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project.

Authors:  Onofre Combarros; Donald R Warden; Naomi Hammond; Mario Cortina-Borja; Olivia Belbin; Michael G Lehmann; Gordon K Wilcock; Kristelle Brown; Patrick G Kehoe; Rachel Barber; Eliecer Coto; Victoria Alvarez; Panos Deloukas; Rhian Gwilliam; Reinhard Heun; Heike Kölsch; Ignacio Mateo; Abderrahim Oulhaj; Alejandro Arias-Vásquez; Maaike Schuur; Yurii S Aulchenko; M Arfan Ikram; Monique M Breteler; Cornelia M van Duijn; Kevin Morgan; A David Smith; Donald J Lehmann
Journal:  BMC Med Genet       Date:  2010-11-11       Impact factor: 2.103

9.  Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.

Authors:  Paul Hollingworth; Denise Harold; Rebecca Sims; Amy Gerrish; Jean-Charles Lambert; Minerva M Carrasquillo; Richard Abraham; Marian L Hamshere; Jaspreet Singh Pahwa; Valentina Moskvina; Kimberley Dowzell; Nicola Jones; Alexandra Stretton; Charlene Thomas; Alex Richards; Dobril Ivanov; Caroline Widdowson; Jade Chapman; Simon Lovestone; John Powell; Petroula Proitsi; Michelle K Lupton; Carol Brayne; David C Rubinsztein; Michael Gill; Brian Lawlor; Aoibhinn Lynch; Kristelle S Brown; Peter A Passmore; David Craig; Bernadette McGuinness; Stephen Todd; Clive Holmes; David Mann; A David Smith; Helen Beaumont; Donald Warden; Gordon Wilcock; Seth Love; Patrick G Kehoe; Nigel M Hooper; Emma R L C Vardy; John Hardy; Simon Mead; Nick C Fox; Martin Rossor; John Collinge; Wolfgang Maier; Frank Jessen; Eckart Rüther; Britta Schürmann; Reiner Heun; Heike Kölsch; Hendrik van den Bussche; Isabella Heuser; Johannes Kornhuber; Jens Wiltfang; Martin Dichgans; Lutz Frölich; Harald Hampel; John Gallacher; Michael Hüll; Dan Rujescu; Ina Giegling; Alison M Goate; John S K Kauwe; Carlos Cruchaga; Petra Nowotny; John C Morris; Kevin Mayo; Kristel Sleegers; Karolien Bettens; Sebastiaan Engelborghs; Peter P De Deyn; Christine Van Broeckhoven; Gill Livingston; Nicholas J Bass; Hugh Gurling; Andrew McQuillin; Rhian Gwilliam; Panagiotis Deloukas; Ammar Al-Chalabi; Christopher E Shaw; Magda Tsolaki; Andrew B Singleton; Rita Guerreiro; Thomas W Mühleisen; Markus M Nöthen; Susanne Moebus; Karl-Heinz Jöckel; Norman Klopp; H-Erich Wichmann; V Shane Pankratz; Sigrid B Sando; Jan O Aasly; Maria Barcikowska; Zbigniew K Wszolek; Dennis W Dickson; Neill R Graff-Radford; Ronald C Petersen; Cornelia M van Duijn; Monique M B Breteler; M Arfan Ikram; Anita L DeStefano; Annette L Fitzpatrick; Oscar Lopez; Lenore J Launer; Sudha Seshadri; Claudine Berr; Dominique Campion; Jacques Epelbaum; Jean-François Dartigues; Christophe Tzourio; Annick Alpérovitch; Mark Lathrop; Thomas M Feulner; Patricia Friedrich; Caterina Riehle; Michael Krawczak; Stefan Schreiber; Manuel Mayhaus; S Nicolhaus; Stefan Wagenpfeil; Stacy Steinberg; Hreinn Stefansson; Kari Stefansson; Jon Snaedal; Sigurbjörn Björnsson; Palmi V Jonsson; Vincent Chouraki; Benjamin Genier-Boley; Mikko Hiltunen; Hilkka Soininen; Onofre Combarros; Diana Zelenika; Marc Delepine; Maria J Bullido; Florence Pasquier; Ignacio Mateo; Ana Frank-Garcia; Elisa Porcellini; Olivier Hanon; Eliecer Coto; Victoria Alvarez; Paolo Bosco; Gabriele Siciliano; Michelangelo Mancuso; Francesco Panza; Vincenzo Solfrizzi; Benedetta Nacmias; Sandro Sorbi; Paola Bossù; Paola Piccardi; Beatrice Arosio; Giorgio Annoni; Davide Seripa; Alberto Pilotto; Elio Scarpini; Daniela Galimberti; Alexis Brice; Didier Hannequin; Federico Licastro; Lesley Jones; Peter A Holmans; Thorlakur Jonsson; Matthias Riemenschneider; Kevin Morgan; Steven G Younkin; Michael J Owen; Michael O'Donovan; Philippe Amouyel; Julie Williams
Journal:  Nat Genet       Date:  2011-04-03       Impact factor: 38.330

10.  Interleukin-8-251T > A, Interleukin-1α-889C > T and Apolipoprotein E polymorphisms in Alzheimer's disease.

Authors:  Alex Augusto Vendramini; Roger Willian de Lábio; Lucas Trevizani Rasmussen; Nathali Mattiuzo Dos Reis; Thais Minett; Paulo Henrique Ferreira Bertolucci; Marcela Augusta de Souza Pinhel; Dorotéia Rossi Silva Souza; Diego Robles Mazzotti; Marília de Arruda Cardoso Smith; Spencer Luiz Marques Payão
Journal:  Genet Mol Biol       Date:  2011-03-01       Impact factor: 1.771

View more
  8 in total

Review 1.  Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs.

Authors:  M A Daniels; C Kan; D M Willmes; K Ismail; F Pistrosch; D Hopkins; G Mingrone; S R Bornstein; A L Birkenfeld
Journal:  Pharmacogenomics J       Date:  2016-07-19       Impact factor: 3.550

2.  PPAR-α agonist regulates amyloid-β generation via inhibiting BACE-1 activity in human neuroblastoma SH-SY5Y cells transfected with APPswe gene.

Authors:  Hua Zhang; Ying Gao; Pei-feng Qiao; Feng-li Zhao; Yong Yan
Journal:  Mol Cell Biochem       Date:  2015-06-20       Impact factor: 3.396

Review 3.  Molecular basis of etiological implications in Alzheimer's disease: focus on neuroinflammation.

Authors:  Rituraj Niranjan
Journal:  Mol Neurobiol       Date:  2013-02-19       Impact factor: 5.590

4.  Genetic polymorphisms of interleukin genes and the risk of Alzheimer's disease: An update meta-analysis.

Authors:  Myung-Jin Mun; Jin-Ho Kim; Ji-Young Choi; Won-Cheoul Jang
Journal:  Meta Gene       Date:  2016-01-11

Review 5.  Alzheimer's Disease, a Lipid Story: Involvement of Peroxisome Proliferator-Activated Receptor α.

Authors:  Francisco Sáez-Orellana; Jean-Noël Octave; Nathalie Pierrot
Journal:  Cells       Date:  2020-05-14       Impact factor: 6.600

6.  Analysis of transcription factor- and ncRNA-mediated potential pathogenic gene modules in Alzheimer's disease.

Authors:  Cuihua Zou; Jie Wang; Xiaohua Huang; Chongdong Jian; Donghua Zou; Xuebin Li
Journal:  Aging (Albany NY)       Date:  2019-08-16       Impact factor: 5.682

Review 7.  EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Disease.

Authors:  Vladimir Khavinson; Natalia Linkova; Ekaterina Kozhevnikova; Svetlana Trofimova
Journal:  Molecules       Date:  2020-12-31       Impact factor: 4.411

8.  Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium.

Authors:  Timothy J Hohman; William S Bush; Lan Jiang; Kristin D Brown-Gentry; Eric S Torstenson; Scott M Dudek; Shubhabrata Mukherjee; Adam Naj; Brian W Kunkle; Marylyn D Ritchie; Eden R Martin; Gerard D Schellenberg; Richard Mayeux; Lindsay A Farrer; Margaret A Pericak-Vance; Jonathan L Haines; Tricia A Thornton-Wells
Journal:  Neurobiol Aging       Date:  2015-11-06       Impact factor: 4.673

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.